High-quality clinical practice guidelines for low back pain demonstrate substantial agreement overall. However, more than one-third of treatment recommendations conflict across guidelines. Which category of...
A large 2023–2024 survey of 21,000 US adults provides updated, medication-specific prevalence data on OTC and prescription use within a 7-day window. Do you know how many adults reported taking at least one...
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
Acute HIV-1 infection presents unique challenges—and opportunities—for intervention. This 30-second quiz tests your knowledge of essential clinical concepts, from diagnosis to early treatment strategies.
...
Agitation in Alzheimer disease isn’t always what it seems. Test your knowledge of the medical, neurologic, and behavioral factors clinicians should consider.
At the 2025 AACE Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving use of GLP-1–based therapies beyond diabetes and obesity, highlighting novel indications, ongoing research,...
A recent clinical trial on adjuvant therapy for endometrial cancer investigated the impact of pembrolizumab on disease-free survival. But which patient population saw the most significant benefit? Test your...
A recent study explores the long-term safety and efficacy of deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate-to-severe plaque psoriasis. Do you know the role TYK2 plays in...
A recent study on momelotinib's effectiveness in patients with myelofibrosis reveals key findings from the SIMPLIFY-1 and SIMPLIFY-2 trials. Can you identify the treatment's impact on symptom response? Test...
